Worst case scenario
Kim Jong Un has, to widespread surprise,announced that the DPRK is facing an explosive Covid epidemic. The surprise, of course, is not that it is happening, but they he has admitted it. The official story out of North Korea is that they had succeeded in keeping the virus out of the country entirely, by closing borders, until recently. Then this catastrophe happened.Many people are skeptical of that account and believe the virus must have been in the country earlier, but I ' m inclined to think it may be true because whenever it arrived, we would almost certainly have seen widespread infection, sickness and death. The count...
Source: Stayin' Alive - May 20, 2022 Category: American Health Source Type: blogs
Virtual Clinical Trials: Interview with Ivan Jarry, CEO at ObvioHealth
Decentralized and virtual clinical trials are gaining prominence, particularly since the COVID-19 pandemic which made it difficult for trial participants to attend in-person appointments. However, conducting clinical trials remotely has a host of potential benefits beyond reducing COVID-19 transmission, including improved patient compliance, real-world data, real-time data, and reduced costs.
ObvioHealth is championing this approach to clinical trials, and through a partnership with Renovia, completed the first fully virtual clinical trial in urogynecology, which investigated the leva Pelvic Health System. The leva devi...
Source: Medgadget - May 16, 2022 Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Ob/Gyn Urology clinical trials ObvioHealth Source Type: blogs
Digital & Tech Are Changing Pfizer: Pharma Co ’s Chief Digital & Technology Officer Takes Us Inside
By JESSICA DaMASSA, WTF HEALTH
What does digital transformation look like at a global healthcare giant like Pfizer? Lidia Fonseca, Pfizer’s Chief Digital & Technology Officer, shares her strategy for building the life sciences company’s digital data and technology solutions, including her thinking about digital therapeutics, digital diagnostics, and digital biomarkers. As Lidia puts it, this is not about trying to simply implement a “digital strategy,” but is, instead, about building a “business strategy for digital world.”
There’s probably no better story that illustrates how that “business strat...
Source: The Health Care Blog - May 11, 2022 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Health Technology Jessica DaMassa WTF Health digital health Lidia Fonseca Pfizer Source Type: blogs
Pfizer and Moderna must share vaccine technology [PODCAST]
“Pfizer has a particular onus to help intervene globally as one of the largest and most profitable pharmaceutical companies in the world. With its immense capital power, Pfizer should shift some of their spending from national ads promoting their vaccine product in a country that has large booster vaccine availability to sharing the technology thatRead more …Pfizer and Moderna must share vaccine technology [PODCAST] originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - April 18, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/the-podcast-by-kevinmd" rel="tag" data-wpel-link="internal" > The Podcast by KevinMD < /a > < /span > Tags: Podcast COVID Infectious Disease Source Type: blogs
TWiV 877: COVID-19 clinical update #106 with Dr. Daniel Griffin
In COVID-19 clinical update #106, Daniel Griffin covers failure of ivermectin to improve hospitalization, increased hospitalization of children with Omicron, seroconversion of children versus adults, effectiveness of Pfizer mRNA vaccine in children, high vaccine effectiveness in Finland against Omicron, distinct long COVID clinical phenotypes, and estimating worldwide excess mortality. (Source: virology blog)
Source: virology blog - March 19, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody pandemic SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 2)
By DAVID WARMFLASH, MD
This is part 2 of David Warmlash’s takedown of Robert W. Malone’s appearance (transcript) on the Rogan podcast. Part 1 is here
Menstruation and Fertility
Much more than the line about reproductive damage in the Wisconsin News clip that we used to open the story, Malone used the Rogan interview to dive more deeply into the topic, starting with:
…there’s a huge number of dysmenorrhea and menometrorrhagia…
By that, he meant excessive menstrual cramping and very heavy, often irregular, bleeding, which he followed up with:
…they DENY it…
Judging by other parts ...
Source: The Health Care Blog - March 18, 2022 Category: Consumer Health News Authors: matthew holt Tags: COVID-19 Health Policy antivaxxer COVID-19 vaccine David Warmflash Joe Rogan Robert Malone Source Type: blogs
The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 1)
By DAVID WARMFLASH, MD
Robert W. Malone, MD MS, is a physician-scientist who will live in infamy, thanks to the Joe Rogan Experience Podcast boosting his visibility this past December regarding his criticism of COVID-19 vaccines, particularly the mRNA vaccines (Moderna and Pfizer-BioNTech). Subsequently, Malone was banned from Twitter, which further boosted his celebrity status. Describing himself as the inventor of mRNA vaccine technology, he has been reaching a growing number of people with a narrative that makes COVID-19 vaccination sound scary. We cannot embed clips from the Rogan interview, which lasted about three...
Source: The Health Care Blog - March 17, 2022 Category: Consumer Health News Authors: matthew holt Tags: COVID-19 Health Policy antivaxxer COVID-19 vaccine David Warmflash Joe Rogan Robert Malone Source Type: blogs
Freeze Peach
Michelle Mello, writing in the JAMA Health Forum, is frustrated that the Supreme Court considers vaccine disinformation to be protected under the first amendment. As many as 12 million persons may have forgone COVID-19 vaccination in the US because of misinformation, resulting in anestimated 1200 excess hospitalizations and 300 deaths per day. If 5 fully loaded 747s crashed each week due to wrong information, regulators would be apoplectic. She points out that there are many circumstances in which potentially harmful falsehoods can be policed. This includes advertising -- an ad claiming that Ivermectin...
Source: Stayin' Alive - March 11, 2022 Category: American Health Source Type: blogs
What's new in midwifery - COVID-19
Remdesivir (an antiviral) for pregnant patients with COVID-19. mRNA COVID vaccines in pregnancy - mRNA vaccines included are the Pfizer/BioNTech and the Moderna. (Source: Browsing)
Source: Browsing - March 11, 2022 Category: Databases & Libraries Tags: midwifery Source Type: blogs
People over profit: Pfizer and Moderna must share vaccine technology
One year ago, the FDA granted emergency use authorization of mRNA COVID-19 vaccines in the U.S., and nearly 549 million total vaccine doses have been given since. These vaccines have been safe, effective methods in preventing infection and death from COVID-19. Vaccine recipients had a lower overall risk of death from non-COVID-19 disease compared toRead more …People over profit: Pfizer and Moderna must share vaccine technology originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 3, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/amber-gipson-fine" rel="tag" > Amber Gipson-Fine, MPH < /a > < /span > Tags: Meds COVID Infectious Disease Source Type: blogs
Why is Covaxin not in the FDA ’s toolbox? [PODCAST]
This episode is sponsored by Athelas, the number one provider of remote patient monitoring.“As a clinician who has received two Pfizer doses and a booster without any side effects, I wholeheartedly embrace vaccination to solve this pressing public health crisis. The key is for policymakers to identify the best tool for the job (i.e.,Read more …Why is Covaxin not in the FDA’s toolbox? [PODCAST] originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - February 13, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/the-podcast-by-kevinmd" rel="tag" > The Podcast by KevinMD < /a > < /span > Tags: Podcast COVID Source Type: blogs
5 COVID-19 Discussions That Will Dominate 2022
Discussions That Will Dominate 2022 appeared first on The Medical Futurist. (Source: The Medical Futurist)
Source: The Medical Futurist - January 11, 2022 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Covid-19 Forecast Artificial Intelligence in Medicine Science Fiction vaccination pandemic vaccine pfizer fatigue booster Source Type: blogs
The New Business Coup? Increasing Evidence that Large Health Care Corporations are Funding Threats to Democracy
(Source: Health Care Renewal)
Source: Health Care Renewal - January 9, 2022 Category: Health Management Tags: AstraZeneca Blue Cross CIGNA CVS dark money Eli Lilly Johnson and Johnson Merck Pfizer Source Type: blogs
FDA Finally Grants Patients Access to Molnupiravir
Jeffrey A. SingerYesterday the Food and Drug Administration gave emergency use authorization (EUA) to the antiviral drugPaxlovid,more than a month after its manufacturer, Pfizer, submitted its application. This pill, if taken within the first few days of a COVID-19 infection, has been found to be 89 percent effective in preventing progression of the disease to hospitalization. Clinical trials found no patients takingPaxlovid died from the virus.Seventy ‐four days ago, Merck applied for an EUA for its antiviral molnupiravir. If taken in the first few days of COVID infection it is 30 percent effective in preventing ...
Source: Cato-at-liberty - December 23, 2021 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
Hostage Crisis Ends On Day 73 —American Patients Now Have Access to One Antiviral Pill
Jeffrey A. SingerEarlier this week I wrote about foot ‐dragging by the Food and Drug Administration regarding approval of two highly effective antiviral pills. With the omicron variant of COVID-19 rapidly spreading throughout the population, infecting both vaccinated and unvaccinated, these pills becomes even more important.Merck applied to the FDA for Emergency Use Authorization (EUA) of its antiviral molnupiravir on October 11, 2021 —73 days ago. The drug was approved for emergency use in the U.K. on November 4. It is 30 percent effective in preventing COVID infections (including the omicron variant) from progr...
Source: Cato-at-liberty - December 22, 2021 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
